HBIO Past Earnings image   This HBIO past earnings page last updated 8/5/2022
HBIO Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 20228/3/20220.050
Q1 20225/4/20220.040
Q4 20213/8/20220.080
Q3 202111/3/20210.060
Q2 20218/5/20210.060
Q1 20215/6/20210.050
Q4 20203/10/20210.080
Q3 202011/5/20200.040
Q2 20208/5/20200.050
Q1 20205/5/2020-0.010
Q4 20192/26/20200.080
Q3 201911/5/20190.040
Q2 20197/25/20190.040
Q1 20195/2/20190.020
Q4 20182/28/20190.07
Q3 201810/25/20180.04
Q2 20187/26/20180.07
Q1 20185/2/20180.03
Q4 20173/1/20180.05
Q3 201710/26/20170.03
Q2 20177/27/20170.03
Q1 20174/27/20170.02
Q4 20163/9/20170.04
Q3 201610/27/20160.03
Q2 20167/28/20160.03
Q1 20165/12/20160.05
Q4 20154/12/20160.03
Q3 201510/29/20150.03
Q2 20157/30/20150.05
Q1 20154/30/20150.02
Q4 20142/26/20150.1
Q3 201410/30/20140.06
Q2 20147/31/20140.06
Q1 20145/1/20140.05
Q4 20132/27/20140.05
Q3 201310/31/20130.05
Q2 20138/1/2013-0.01
Q1 20135/2/20130.03
Q4 20122/28/20130.01
Q3 201211/1/20120.04
HBIO Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/3/20220.03B
Q1 20225/4/20220.03B
Q4 20213/8/20220.03B
Q3 202111/3/20210.03B
Q2 20218/5/20210.03B
Q1 20215/6/20210.03B
Q4 20203/10/20210.03B
Q3 202011/5/20200.02B
Q2 20208/5/20200.02B
Q1 20205/5/20200.02B
Q4 20192/26/20200.03B
Q3 201911/5/20190.03B
Q2 20197/25/20190.03B
Q1 20195/2/20190.03B
Q4 20182/28/201933.94M
Q3 201810/25/201828.71M
Q2 20187/26/201831.52M
Q1 20185/2/201826.76M
Q4 20173/1/201827.46M
Q3 201710/26/201725.05M
Q2 20177/27/201725.21M
Q1 20174/27/201724.16M
Q4 20163/9/201726.41M
Q3 201610/27/201625.01M
Q2 20167/28/201626.14M
Q1 20165/12/201626.96M
Q4 20154/12/201628.37M
Q3 201510/29/201525.73M
Q2 20157/30/201528.80M
Q1 20154/30/201525.80M
Q4 20142/26/201530.36M
Q3 201410/30/201425.40M
Q2 20147/31/201427.00M
Q1 20145/1/201425.89M
Q4 20132/27/201427.90M
Q3 201310/31/201325.10M
Q2 20138/1/201326.10M
Q1 20135/2/201326.10M
Q4 20122/28/201328.25M
Q3 201211/1/201226.10M
Quotes delayed 20 minutes

Email EnvelopeFree HBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Harvard Bioscience (HBIO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

HCA Past Earnings
HCWB Past Earnings
HEPA Past Earnings
HGEN Past Earnings
HJLI Past Earnings
HNGR Past Earnings
HOLX Past Earnings
HOOK Past Earnings
HOTH Past Earnings
HOWL Past Earnings

HBIO Past Earnings Q&A

What was the best and worst HBIO past earnings results?
For Harvard Bioscience, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest HBIO past earnings result in our data set was 0.1/share posted in Q4 2014, while the lowest was in Q1 2020 when HBIO posted -0.010/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2018 when HBIO reported 33.94M in revenue, while the quarter with the lowest revenue in our data set was Q2 2020 at 0.02B of revenue.

  Suggested answer: There are 40 HBIO past earnings results in our data set.

On this page we presented the HBIO past earnings date information for Harvard Bioscience. Reviewing that HBIO Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2014, when HBIO posted adjusted EPS of 0.1/share. Meanwhile the lowest HBIO past earnings result was in Q1 2020, when HBIO posted adjusted EPS of -0.010/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2018 when HBIO reported 33.94M in revenue, while the smallest revenue quarter was Q2 2020 when HBIO reported 0.02B in revenue.

Any self directed investor doing their due diligence on HBIO or any other given stock can benefit from researching all of the Harvard Bioscience past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Harvard Bioscience past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for HBIO. Thanks for visiting, and the next time you need to research HBIO past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: WRE Next Dividend Date, Funds Holding Valero Energy, Institutional Holders of FFIE.

 

HBIO Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.